Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical …

DW Park, YH Kim, HG Song, JM Ahn, J Oh… - Journal of the American …, 2011 - jacc.org
Objectives: We performed the long-term (5-year) follow-up of a large cohort of patients who
underwent drug-eluting stent (DES) or coronary artery bypass graft (CABG) surgery for …

5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy …

Y Onuma, JJ Wykrzykowska, S Garg, P Vranckx… - JACC: Cardiovascular …, 2011 - jacc.org
Objectives: We compared the 5-year outcomes of diabetic patients with multivessel disease
treated with sirolimus-eluting stents (SES), bare-metal stents (BMS), and coronary artery …

Percutaneous coronary interventions in the diabetic patient: where do we stand?

JA Bittl - Circulation: Cardiovascular Interventions, 2015 - Am Heart Assoc
Patients with DM have an impaired response to clopidogrel, but it has been unclear whether
this is caused by altered metabolism or an upregulation of the platelet-membrane P2Y12 …

Impact of diabetes and early revascularization on the need for late and repeat procedures

A Orbach, DA Halon, R Jaffe, R Rubinshtein… - Cardiovascular …, 2018 - Springer
Background Coronary artery disease often progresses more rapidly in diabetics, but the
integrated impact of diabetes and early revascularization status on late or repeat …

Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE …

Z Oqab, V Kunadian, DA Wood, RF Storey… - Circulation …, 2023 - Am Heart Assoc
BACKGROUND: In the COMPLETE trial (Complete Versus Culprit-Only Revascularization to
Treat Multivessel Disease After Early PCI for STEMI), a strategy of complete …

Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery …

MS Lee, T Yang, J Dhoot, Z Iqbal, H Liao - The American journal of …, 2010 - Elsevier
This meta-analysis was undertaken to assess the efficacy and safety of coronary artery
bypass grafting (CABG) compared to drug-eluting stenting (DES) in patients with diabetes …

Five-year outcomes of percutaneous versus surgical coronary revascularization in patients with diabetes mellitus (from the CREDO-Kyoto PCI/CABG Registry Cohort …

A Marui, T Kimura, N Nishiwaki, K Mitsudo… - The American Journal of …, 2015 - Elsevier
We investigated the impact of diabetes mellitus on long-term outcomes of percutaneous
coronary intervention (PCI) in the drug-eluting stent era versus coronary artery bypass …

Four-year outcome of OPCAB no-touch with total arterial Y-graft: making the best treatment a daily practice

WB Halbersma, SC Arrigoni, G Mecozzi… - The Annals of thoracic …, 2009 - Elsevier
BACKGROUND: A retrospective, single-center 4-year clinical study of the off-pump coronary
artery bypass grafting no-touch technique with arterial conduits (Y-graft) was compared with …

Outcomes with drug-coated balloons in percutaneous coronary intervention in diabetic patients

M Megaly, A Ali, B Abraham, C Khalil, M Zordok… - Cardiovascular …, 2020 - Elsevier
Background Percutaneous coronary intervention (PCI) in patients with diabetes mellitus
(DM) remains associated with inferior clinical outcomes and an increased risk of restenosis …

Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients

U Benedetto, G Melina, E Angeloni… - European journal of …, 2009 - academic.oup.com
Objective: Coronary artery bypass grafting (CABG) has been shown to provide better results
than percutaneous coronary intervention (PCI) in multivessel coronary disease. Drug-eluting …